HomeBUSINESS
BUSINESS

Takeda Joins Liver-Focused Biotech Launch with US$100 Million Partnership
(Aug.10.2018)

Takeda Pharmaceutical has struck a strategic partnership with Ambys Medicines, a newborn US biotech specializing in liver diseases, in a bid to help drive the Redwood City, California company’s research across various modalities of treatments, to which it gained an option outside the US ...
(LOG IN FOR FULL STORY)